Most cases of BC recurrence appear to be age-dependent and correlated with an advanced stage at diagnosis, luminal B molecular subtype, mastectomy, treatment with aromatase inhibitors, and upper-outer quadrant localization of the primary BC tumor. This evidence concerns the gene CYP19A1 and breast cancer.